Article

The future promise of advanced therapies in ophthalmology

Six years after the first approved gene therapy in ophthalmology, the field is seeing a flurry of activity in innovative cell and gene therapy (CGT) studies addressing high unmet needs. Here’s what could be in store for the future.

Louis Cicchini
Director, Scientific Affairs, Cell & Gene Therapy at Cencora

Fill out the form below to read more

Pardot Form

Related resources

Article

Harnessing AI and advanced analytics to revolutionize PV signal management

Learn more

Webinar

Navigating global policy shifts: Implications for Europe's pharma landscape

Learn more

Article

The growing case for AI to support pharmacovigilance: World Drug Safety Congress Americas key takeaways

Learn more

Connect with our cell and gene therapy team

Schedule some time with our cell and gene therapy experts today. We look forward to hearing from you.